Pier 88 Investment Partners’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-26,415
Closed -$84.8K 97
2024
Q1
$84.8K Buy
26,415
+1,620
+7% +$6.27K 0.02% 100
2023
Q4
$121K Sell
24,795
-51,700
-68% -$236K 0.03% 90
2023
Q3
$417K Buy
76,495
+4,870
+7% +$32.2K 0.1% 78
2023
Q2
$481K Hold
71,625
0.12% 76
2023
Q1
$632K Buy
71,625
+14,420
+25% +$127K 0.15% 65
2022
Q4
$437K Hold
57,205
0.11% 69
2022
Q3
$407K Buy
57,205
+1,940
+4% +$18.3K 0.1% 78
2022
Q2
$447K Buy
55,265
+33,660
+156% +$296K 0.11% 82
2022
Q1
$300K Sell
21,605
-10,870
-33% -$171K 0.11% 73
2021
Q4
$911K Buy
32,475
+14,050
+76% +$431K 0.19% 77
2021
Q3
$626K Sell
18,425
-10,337
-36% -$374K 0.19% 83
2021
Q2
$1.18M Buy
28,762
+11,900
+71% +$463K 0.34% 71
2021
Q1
$679K Sell
16,862
-1,110
-6% -$60.1K 0.23% 80
2020
Q4
$1.06M Sell
17,972
-6,670
-27% -$344K 0.34% 56
2020
Q3
$1.2M Buy
24,642
+11,732
+91% +$493K 0.36% 61
2020
Q2
$625K Buy
+12,910
New +$471K 0.18% 88

Other funds holding ADPT

Pier 88 Investment Partners's ADPT Position: Q2 2024 in Review

Pier 88 Investment Partners sold out of Adaptive Biotechnologies (ADPT) in Q2 2024, closing a stake of 26,415 shares — an estimated $84.8K sold.

Pier 88 Investment Partners first reported a position in ADPT in Q2 2020 and held it in 16 quarters. The position peaked at $1.2M in Q3 2020. 176 funds tracked by Wall St. Rank hold ADPT as of Q2 2024.

  • Pier 88 Investment Partners reported no remaining Adaptive Biotechnologies position as of Q2 2024 after selling out during the quarter.
  • Pier 88 Investment Partners sold 26,415 Adaptive Biotechnologies shares in Q2 2024, an estimated $84.8K.
  • Pier 88 Investment Partners first reported a position in Adaptive Biotechnologies in Q2 2020 and held it in 16 quarters.
  • Pier 88 Investment Partners's Adaptive Biotechnologies position peaked at $1.2M in Q3 2020.
  • 176 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2024.

Based on Pier 88 Investment Partners's 13F filing for Q2 2024, filed 6 Aug 2024.